“NIH COVID-19 Treatment Guidelines Strongly Recommend Use of REGEN-COV™ (casirivimab with imdevimab) in Outpatients at High Risk of Clinical Progression”
This article mentions that under the EUA, REGEN-COV is available throughout the U.S. and information on availability can be found through us!
Login
When you login, you will be directed to admin.infusioncenter.org. When you get there:
You will receive an email with a link to click that will log you into the resources section of the locator, which includes your claimed and/or activated infusion center(s).
Please note: you will have to enter your email each time as we no longer have passwords for extra security. This login process is separate from the forum.
If you have questions about the email address associated with the location, how to add or claim a center, how to purchase a resource, etc., please email our Member Relations lead, Ashley Kana at [email protected].
